Atlas Trials

Irbesartan-Hydrochlorothiazide Phase IV Study: Treatment of Hypertension in Chinese Population

Clinical trial NCT00847834 · COMPLETED

Trial details

NCT number
NCT00847834
Sponsor
Sanofi
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Hypertension
Start date
2003-12-01
Primary completion
2004-06-01
Enrollment
968

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.